Search Results 961-970 of 18098 for monoclonal antibody

  1. Evaluating The Safety And Efficacy Of TLD In Patients With COPD - Mayo Clinic

    * Participant started taking a monoclonal antibody (mAb), or a PDE3/PDE4 inhibitor less than 6 months prior to screening. (Participants on these medications ...

  2. A Study Of Hematopoiesis In Patients With Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), And Healthy Controls - Mayo Clinic

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  3. Advancing a new era of regenerative medicine - Mayo Clinic News Network

    "Mayo Clinic has the clarity of vision to lead in this space. I'm grateful to be a part of it." ###. What's the latest on monoclonal antibody therapies to ...

  4. Monoclonal gammopathy of undetermined significance (MGUS) - Doctors and departments - Mayo Clinic

    A condition of blood plasma that produces altered antibodies that increase the risk of blood cancers and other conditions.

  5. Precision diagnosis of MOG antibody-associated disease is critical for timely, targeted therapy - Mayo Clinic

    Mayo Clinic offers the first coordinated, multidisciplinary clinic in the world that is devoted specifically to MOGAD, a rare antibody-mediated inflammatory ...

  6. Recent COVID-19 infection could affect recommended timing of your COVID-19 vaccination - Mayo Clinic News Network

    You received convalescent plasma or monoclonal antibody in the last 90 days. Health care providers stress that getting vaccinated for COVID-19 is an ...

  7. A Study Of CA-4948 In Patients With Relapsed Or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

    Relapse is defined per the consensus panel recommendations from the Sixth International Workshop on WM as reappearance of monoclonal IgM protein and/or ...

  8. A Study Of ABBV-085, An Antibody Drug Conjugate, For Patients With Advanced Solid Cancer Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety and drug/body interactions of ABBV-085, and to determine the recommended future study dose (alone or in ...

  9. Coronavirus disease 2019 (COVID-19) - Symptoms and causes - Mayo Clinic

    In the U.S., the Food and Drug Administration (FDA) also has authorized the monoclonal antibody pemivibart (Pemgarda) to prevent COVID-19 in some people ...

  10. Mayo Clinic Q & A - Dr. Gregory Poland - YouTube Audio for C...

    monoclonal antibody by sub q injections, subcutaneous injection, rather than requiring intravenous infusion, and at half the dose. So, that's going to be ...